 |
|
Cerebrospinal Fluid Amine MetabolitesRelations`phips With Behavioral Measurements in Depressed, Manic, and Healthy Control Subjects
D. Eugene Redmond, Jr, MD;
Martin M. Katz, PhD;
James W. Maas, MD;
Alan Swann, MD;
Regina Casper, MD;
John M. Davis, MD
Arch Gen Psychiatry. 1986;43(10):938-947.
Abstract
• We studied 99 hospitalized depressed, 14 manic, and 61 healthy control subjects and evaluated relationships during a drug-free baseline period between behavioral measures (postulated to be associated with brain norepinephrine, dopamine, and serotonin function) and metabolites of these neurotransmitters sampled from lumbar cerebrospinal fluid (CSF): 3-methoxy-4-hydroxyphenylglycol (MHPG), homovanillic acid, and 5-hydroxyindoleacetic acid. Depressed subjects with increased anxiety, agitation, somatization, and sleep disturbance were found to have significantly elevated concentrations of CSF MHPG; this relationship was not found in the healthy controls. A correlation between CSF MHPG level and an anxiety/agitation dimension measured in all subjects was statistically significant but explained a modest portion of the total variance. No consistent relationships were found between CSF MHPG and depression/ retardation, hostility/interpersonal sensitivity, and global severity, nor did any of these measures correlate significantly with the levels of the other monoamine metabolites, although some trends were found. Other factors did not account for the relationships between CSF MHPG and some behavioral measures, including diagnostic subgroup, motor movement, age, sex, and premenopausal or postmenopausal status in women. Suggested relationships among drug treatment modality, eventual treatment outcome, behavioral and mood state at baseline, and these metabolite levels will require further analyses.
Author Affiliations
From the National Institute of Mental Health-Clinical Research Branch Collaborative Program on the Psychobiology of Depression-Biological Studies, Bethesda, Md (Drs Redmond, Katz, Maas, Swann, Casper, and Davis); Neurobehavioral Laboratory and Department of Psychiatry, Yale University School of Medicine, New Haven, Conn (Dr Redmond); Department of Psychiatry, Albert Einstein College of Medicine—Montefiore Medical Center, Bronx, NY (Dr Katz); Department of Psychiatry, University of Texas Health Science Center at San Antonio (Dr Maas); Department of Psychiatry, University of Texas Health Science Center at Houston (Dr Swann); Department of Psychiatry, University of Chicago (Dr Casper); and Illinois State Psychiatric Institute and Department of Psychiatry, University of Illinois, Chicago (Dr Davis).
Footnotes
Accepted for publication Feb 17, 1986.
Reprint requests to Neurobehavioral Laboratory, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510 (Dr Redmond).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Suicide: scientific overview and relevance for trauma care providers
Crandall
Trauma 2007;9:213-220.
ABSTRACT
A Serotonin Transporter Gene Promoter Polymorphism (5-HTTLPR) and Prefrontal Cortical Binding in Major Depression and Suicide
Mann et al.
Arch Gen Psychiatry 2000;57:729-738.
ABSTRACT
| FULL TEXT
Menopause Research and The Dominance of the Biomedical Model 1984-1994
Rostosky and Travis
Psychology of Women Quarterly 1996;20:285-312.
ABSTRACT
Blunted Growth Hormone Response to Clonidine in Patients With Generalized Anxiety Disorder
Abelson et al.
Arch Gen Psychiatry 1991;48:157-162.
ABSTRACT
Cerebrospinal Fluid Correlates of Depression in Huntington's Disease
Kurlan et al.
Arch Neurol 1988;45:881-883.
ABSTRACT
Afternoon Continuous Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol and Age: Distinctive Biologic Subgroups of Endogenous Depression?
Halbreich et al.
Arch Gen Psychiatry 1987;44:804-812.
ABSTRACT
|
